Management of Simulated Patients with Sexually Transmitted Infections by Staff of Retail Pharmacies in Kibera Slums Of Nairobi by Kwena, ZA et al.
September 2008 EAST AFRICAN MEDICAL JOURNAL   419
East African Medical Journal Vol. 85 No. 9 September 2008
MANAGEMENT OF SIMULATED PATIENTS WITH SEXUALLY TRANSMITTED INFECTIONS BY STAFF OF RETAIL 
PHARMACIES IN KIBERA SLUMS OF NAIROBI
Z. A. Kwena, BA, MA. (Geog), Social Scientist/Study Coordinator, Centre for Microbiology Research, Research, Care and Training 
Programme, Kenya Medical Research Institute, P. O. Box 614-40100, Kisumu, Kenya, A. Sharma, Sc.D, Freelance Consultant, 
P.M.B 69 Garki, Abuja, Nigeria, Minna, Nigeria, C. Muga, B.Ed, Social Scientist, Centre for Microbiology Research, Research, 
Care and Training Program Kenya Medical Research Institute, P. O. Box 19464-00202, Nairobi, Kenya, N. Wamae, MSPH, 
PhD, IOD (K), Director, Centre for Microbiology Research, Kenya Medical Research Institute, P. O. Box 19464-00202, Nairobi, 
Kenya, E. A. Bukusi, MBChB, MMed. (Obs & Gyn), MPH, PhD, Co-Director, Research, Care and Training Programme, Centre 
for Microbiology Research, Kenya Medical Research Institute, P. O. Box 19464-00202, Nairobi, Kenya
Request for reprints to: Mr. Z. A. Kwena, Center for Microbiology Research, Research, Care and Training Programme, 
Kenya Medical Research Institute, P. O. Box 614-40100, Kisumu, Kenya
MANAGEMENT OF SIMULATED PATIENTS WITH SEXUALLY TRANSMITTED 
INFECTIONS BY STAFF OF RETAIL PHARMACIES IN KIBERA SLUMS OF 
NAIROBI
Z. A. KWENA, A. SHARMA, C. MUGA, N. WAMAE and E. A. BUKUSI
ABSTRACT
Objective: To evaluate the treatment suggested to sexually transmitted infections (STI) 
self-medicating patients in retail pharmacies.
Design: A descriptive cross-sectional survey.
Setting: Kibera slum, Nairobi City, Kenya.
Subjects: Staff of 50 convenient randomly selected retail pharmacies.
Results: The majority (97%) of the pharmacy staff who attended to self-medicating 
patients asked questions. Most of these questions centered around the onset of the 
stated symptoms, the health of the partner, patient’s current health status and previous 
medications taken. Of the 99 staff evaluated, 60% correctly diagnosed gonorrhoea and 
82% correctly diagnosed genital ulcer disease (GUD). Only nine out of fifty (18%) 
offered the recommended treatment for gonorrhoea and only one individual offered 
recommended treatment for GUD. The most commonly offered treatment for gonorrhoea 
and GUD was metronidazole and penicillin, respectively. Overall, only 10% correctly 
diagnosed both conditions and offered appropriate treatment. The staff also counselled 
patients on a wide range of issues including condom use, abstinence and being faithful, 
contact treatment, seeking prompt treatment and completing treatment.
Conclusion: With only about 10% offering appropriate government recommended 
treatment for gonorrhoea and GUD, these pharmacy staff working in retail pharmacies 
in Kibera slum put slum dwellers seeking care at an increased risk of STI related 
morbidity and transmission due to inappropriate or inadequate treatment.
Recommendation:  To improve management of these conditions, in-service training 
and enforcement of the relevant legislation and policy is needed.
INTRODUCTION
Because of increased health care costs at both public 
and private health facilities among other factors, the 
urban poor often resort to self-medication through 
purchase of medicines from retail pharmacies in 
their neighbourhoods (1,2).  Thus, retail pharmacies 
have increasingly become the first and sometimes the 
only contact of these people with allopathic health 
services.  As such, these pharmacies are important 
sources of advice on disease diagnosis and treatment 
especially in developing countries where many drug-
purchasing decisions maybe unmediated by medical 
professionals (3,4).  The World Health Organisation 
resolution number WHA 47.12 of 1994 recognises 
the key role pharmacy staff play in the health of 
the public and the use of medicines (5). To promote 
rational use of medication, retail pharmacies should 
have qualified staff, who can adequately diagnose 
conditions of self-medicating patients, offer adequate 
420 EAST AFRICAN MEDICAL JOURNAL September 2008 
counselling and refer to other care where and as 
necessary.  Unfortunately, staff in retail pharmacies of 
developing countries may not have basic professional 
training and/or experience (6-8). Hence, they may be 
unable to accurately diagnose diseases or prescribe 
appropriate treatment or advice.  The situation is 
made worse by retail pharmacies situated in urban 
slum areas where the patient population may have 
limited options for informed choice.
 Kenya’s policy that regulates retail pharmaceutical 
outlets requires that they should be run on day-to-day 
basis by a qualified pharmacist or medical doctor 
assisted by qualified pharmaceutical technicians (9). 
As part of the regulation, there should be a display 
of the necessary certifications including training 
qualifications of the pharmacists running the premise. 
However, it is commonly understood that due to 
laxity in the enforcement of this policy, many retail 
pharmacies, especially those situated in urban poor 
areas ignore regulation and engage staff who may 
not have appropriate qualifications but may accept 
lower remuneration.
 Kibera the most populated slum settlement in 
Nairobi City harbours 25% of the city’s population 
and mostly those with lower incomes (10).  High 
medical costs as well as distance and perceived 
lack of confidentiality may deter Kibera residents 
from seeking treatment in public clinics (1,11). 
Consequently, this population may resort to self-
medication through purchase of medicines from retail 
pharmacies. Little information is available on the 
qualifications and competence of pharmacy staff of 
retail pharmacies in urban poor settlements in cities 
in developing countries.
MATERIALS AND METHODS
A cross-sectional survey was conducted using the 
mystery patient method to examine the management 
of STI self-medicating patients by retail pharmacy 
staff. We used gonorrhoea (GC) and genital ulcer 
disease (GUD) in men as tracer diseases. Ethical 
approval was obtained from Kenya Medical Research 
Institute’s (KEMRI) Ethical Review Committee. After 
community mapping of retail pharmacies in Kibera 
slum, we selected a convenience sample of 50 retail 
pharmacies out of the 150 identified. Selection was 
based on their willingness to participate in the study. 
Two data collectors presented to the participating 
retail pharmacies as mystery patients seeking care 
for symptoms of either GUD or GC. We ensured a 
minimum of seven days between first and the second 
mystery patient’s visit to the same retail pharmacy. At 
the target pharmacy, each mystery patient simulated 
one of the following scenarios to elicit required 
information:
(i) Simulated scenario 1 was “I feel sharp burning pain 
when passing urine. There is also thick yellowish 
discharge from my penis. What medicine should 
I take?” and,
(ii) Simulated scenario 2 was “I have several painful 
ulcers in my genitalia. They have smelly pus. What 
should I do?”
This resulted to a total of 100 encounters, 50 from 
each mystery patient. If the mystery patients were 
asked for additional information they provided the 
following details:
(i) He hasn't had any similar symptoms ever 
before. 
(ii) He had had intercourse with a few different 
partners in the past few weeks.
(iii) He doesn't know whether any of the partners 
suffered from anything like this.
(iv) He had not seen a doctor about his problems 
and is willing to accept any suggestion that the 
pharmacy staff provides.
After the treatment was suggested and costed, the 
mystery patients indicated that they did not have 
enough money and left to look for money. They 
declined partial treatment if offered with a promise 
to return to buy the full dose. The mystery patients 
recorded data on how the retail pharmacy staff 
handled them as self-medicating patients presenting 
with symptoms of either GUD or GC in pre-coded 
observation record sheets within 10 minutes of leaving 
the target pharmacy.
 The data were manually checked for completeness 
of the questionnaires and verification of the consistency 
of the responses given. It was then coded and double-
entered into SPSS program (Version 10.0, SPSS Inc., 
Chicago) for analysis. We compared treatment offered 
to mystery patients with the National guidelines 
issued by the Ministry of Health for syndromic 
management of STIs.  The Government recommends 
the treatment of urethral discharge (gonorrhoea) 
with a combination of norfloxacine 800mg stat and 
doxycycline 100mg twice daily for seven days or 
alternatively a combination of spectimycin 2g stat and 
doxycycline 100mg twice daily for seven days if the 
patient does not appropriately respond to first line 
treatment. For genital ulcer disease, the Government 
recommends a combination of erythromycin 500mg 
thrice daily for sevens days and an injection of 
benzathine penicillin 2.4mu stat. Patients allergic to 
penicillin are given erythromycin 500mg four times 
daily for 14 days. The alternative treatment to this is 
ceftriaxone 250mg stat.
RESULTS
Questions asked: After mystery patients presented both 
scenarios 1 and 2, 97% of the pharmacy staff asked 
questions. Most of the staff (94%) asked questions about 
the onset of the symptoms. Other questions were on 
the health of the partner (77%), requesting the patient 
to give more details on the problem (64%), the patient’s 
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current health status (56%), previous medications taken 
(53%), sexual activities in the past (14%), the period 
of time the patient had known the partner (4%) and 
known allergy to any medication (1%).
Diagnosis: Thirty out of fifty (60%) of the staff of 
pharmacies visited correctly diagnosed scenario 1 as 
gonorrhoea while seven out of fifty (14%) diagnosed 
it incorrectly as syphilis and others simply diagnosed 
it as an STD (12%).  About 82% of the staff of the 
pharmacies visited correctly diagnosed scenario 2 as 
genital ulcer disease that can be attributed to syphilis, 
genital herpes and/or chancroid (Table 1). The others 
(18%) diagnosed it either as gonorrhoea, urinary tract 
infection and one staff was not sure what disease it 
was. Overall, 60-82% of the pharmacy staff correctly 
diagnosed gonorrhoea and GUD.
Medication offered for treatment: While 80% of the staff 
offered a drug regimen that included metronidazole 
to treat gonorrhoea, 48% offered a drug regimen that 
included benzathine penicillin injection to treat GUD 
(Table 2).  A total of eighty six out of one hundred (86%) 
of those who offered treatment for both conditions 
gave drug regimens with at least three different 
combinations. While tewnty seven out of thirty (90%) of 
those who correctly diagnosed GC incorrectly offered 
metronidazole in their drug combinations, twenty three 
out of fourty (58%) who had correct diagnosis of GUD 
offered drug regimen that included penicillin. Of those 
who offered doxycycline and norfloxacine in their drug 
regimen, nineteen out of thirty (63%)and fourteen out 
of thirty (47%), respectively had correct diagnosis of 
gonorrhoea. Other than penicillin, those who had 
correct diagnosis GUD offered: Doxycycline (30%), 
erythromycin (28%) and metronidazole (18%).
Table 1
Diagnosis made by staff of retail pharmacies evaluated for scenario 1(GC) and scenario 2 (GUD)
Diagnosis Scenario 1(GC) Scenario 2 (GUD)
 Frequency (%) Frequency (%)
Gonorrhoea 30 60 5 10
Syphilis 7 14 32 65
Gonorrhoea and syphilis 1 2 0 0
Gonorrhoea and STD 1 2 0 0
Gonorrhoea or syphilis 3 6 0 0
STD 6 12 0 0
Syphilis or chancroid 1 2 2 4
Syphilis and STD 1 2 0 0
Chancroid 0 0 6 12
Urinary tract infection 0 0 3 7
Not sure 0 0 1 2
Total 50 100 49 100
Table 2
Drugs offered for treatment of scenario 1 (gonorrhoea) and scenario 2 (GUD)
Drug Gonorrhoea Genital ulcer disease
 Frequency (%) Frequency (%)
Metronidazole 40 80 7 14
Doxycycline 26 54 12 25
Ampicilin 14 28 5 10
Pain killers (Brufen and Paracetamol) 15 30 2 4
Tetracycline 2 4 0 0
Penicillin 15 30 23 48
Norfloxacin 18 36 5 10
Clotrimazole 2 4 0 0
Erythromycin 13 26 11 22
Ciprofloxacin 3 6 2 4
Other antibiotics 2 4 5 10
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Partial treatment: Fourteen out of thirty (47%) 
of those who correctly diagnosed GC offered 
government recommended medication but not in 
the recommended dose, frequency or duration of 
treatment. Similarly, three out of fourty (8%) who 
had correct GUD diagnosis offered Government 
recommended treatment but not the correct dose, 
frequency or duration of treatment (Table 3). While 
none of the pharmacy staff who had incorrect 
diagnosis for GUD offered government recommended 
treatment, five out of twenty (25%) who had incorrect 
diagnosis for gonorrhoea, nonetheless, offered 
Government recommended treatment but not the 
correct dosage, frequency or duration of treatment. 
For patients who pleaded not to have enough money 
for the cost of drugs prescribed, 69% of the pharmacy 
staff accepted to give half treatment for the patients to 
come for the rest when they get the money, 25% were 
willing to give one drug to begin with as they look 
for more money. Only 4% insisted that the patients 
have enough money for complete treatment before 
they sell to them and 2% referred patients to a public 
health centre. 
88% on being faithful to one partner and contact 
treatment, and 63% counselled on abstinence. They 
also counselled on seeking prompt treatment (25%), 
completing the treatment (25%) and testing for HIV 
(13%). The one individual, who correctly diagnosed 
GUD and offered a Government recommended 
treatment, counselled the patient on the use of 
condoms, seeking prompt treatment in future cases 
and completing the treatment.
DISCUSSION
The majority (97%) of the pharmacy staff who 
attended to self-medicating patients asked questions. 
Most of these questions centered around the onset 
of the stated symptoms, the health of the partner, 
patient’s current health status and previous 
Table 3
Diagnosis and treatment offered without regard to correct dose, frequency and duration of treatment
Diagnosis    Recommended treatment Other treatment
    (Drugs’ strength ignored) (Drugs’ strength ignored)
      Frequency (%) Frequency (%)
                   Gonorrhoea (GC)
Correct diagnosis 14 47 16 53
Incorrect diagnosis 5 25 15 75
               Genital ulcer disease (GUD)
Correct diagnosis 3 8 37 92
Incorrect diagnosis 0 0 9 100
Appropriate treatment: Eight out of thirty (27%) of 
the pharmacy staff who had correctly diagnosed 
gonorrhoea offered a regimen that included 
government recommended medicines adhering 
to the correct dosage, frequency and duration. 
Paradoxically, one out of twenty (5%) who had an 
incorrect diagnosis for gonorrhoea, nonetheless, 
offered the recommended treatment. Overall nine 
out of fifty (18%) of the staff offered the mystery 
patients appropriate treatment for gonorrhoea. The 
pharmacy staff who had correct gonorrhoea diagnosis 
were more likely (OR = 6.909) to offer a regimen 
containing government recommended drugs than 
those who did not although the difference observed 
was not statistically significant (95% C1 =0.97-60.36). 
Those who had correct diagnosis for gonorrhoea were 
1.66 times as likely to offer a regimen that included 
Government recommended drugs as those who had 
misdiagnosis. Likewise, one out of fourty (3%) of 
the staff who had correct GUD diagnosis offered a 
regimen that included government recommended 
medicine for people who are allergic to penicillin or 
erythromycin 500mg four times daily for 14 days. 
Overall, only ten out of ninety nine (10%) of the 
pharmacy staff offered appropriate treatment for 
both gonorrhoea and GUD.
Counselling patients: All pharmacy staff offered 
counselling except one. The counselling mostly 
centered on contact treatment (84%), proper and 
consistent condom use (77%) and completion of the 
treatment (59%). They also counselled on seeking 
prompt treatment in future cases (56%), being faithful 
to one partner (47%), abstinence (19%), correct use 
of medications (17%) and as well counselled patients 
to go for a laboratory test or to see a doctor (9%).  Of 
the eight who had correct diagnosis of gonorrhoea 
and offered a government recommended treatment, 
all (100%) counselled patients on condom use, 
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medications taken. Of the 99 staff evaluated, 60% 
correctly diagnosed gonorrhoea and 82% correctly 
diagnosed GUD. Only nine out of fifty (18%) offered 
the recommended treatment for gonorrhoea and 
only one individual offered recommended treatment 
for GUD. The most commonly offered treatment 
for gonorrhoea and GUD was metronidazole and 
penicillin, respectively. Overall, only 10% correctly 
diagnosed both conditions and offered appropriate 
treatment. The staff also counselled patients on a wide 
range of issues including condom use, abstinence 
and being faithful, contact treatment, seeking prompt 
treatment and completing treatment.
 As per World Health Organisations (WHO) 
guidelines (PI6), proper history taking for correct 
STI diagnosis includes asking specific questions 
to clearly understand the nature of symptoms, 
onset and duration, recent sexual contacts, history 
of previous STDs and care-seeking of the current 
complaint to establish appropriate and adequate 
treatment (12). These staff evaluated were comparable 
in history taking to pharmacy staff in Nairobi’s sub-
locations covering medium, low and very low socio-
economic status of Kibera, Korogocho, Buruburu, 
Kawangware and Mathare (2). The questions asked 
of self-medicating patients were similar in the type 
of questions and details sought. However, the 
same study revealed that those who offered correct 
treatment were more. Additionally, about half of the 
pharmacy staff provided recommended treatment 
compared to only a tenth in this study. In other settings 
in Peru (13) even fewer pharmacy staff, approximately 
1%, provided correct syndromic treatment. 
 The Kenyan national guidelines for STI 
treatment emphasize provision of health information 
and prevention messages to patients. The health 
information is packaged in the form of 4Cs; that is, 
promoting condom use, contact treatment, compliance 
and counselling patients.   While nearly all pharmacy 
staff in Kibera counselled patients on condom use 
and asked about contact treatment, a similar study in 
Nairobi’s medium, low and very low socio-economic 
estates (14) demonstrated that only between 18-48% 
counselled patients on the two aspects. The differences 
in our findings may be partially due to different 
study design. While we focused primarily on retail 
pharmacies, the previous work included both retail 
pharmacies and other health outlets. Furthermore, 
while we used mystery patients, they used both 
mystery patients and interviewed service providers 
as well. Interviews of service providers may result in 
a provider bias that may not reflect actual practice.
 Antibiotic resistance problem in Kenya may 
result from among other factors the laxity of enforcing 
the rules that restrict ‘prescription only’ drugs. 
This is likely to exacerbate the growing instances 
of treatment failures (15, 16). Most of the pharmacy 
staff offered drugs that were not recommended for 
present conditions, and unfortunately even those 
who offered the recommended drugs did not give 
correct dose, frequency or duration. This points to a 
potentially serious problem that could contribute to 
resistance and treatment failures. This occurs despite 
the Government’s elaborate syndromic STI treatment 
guide that is distributed free of charge by National 
AIDS and STDs Control Program (NASCOP) to assist 
medical staff (17). This scenario points to a need for 
more access of these guidelines and a review of law 
enforcement mechanisms for establishment and 
licensing of pharmacists.
 Although the results of this study reveal that 
pharmacy staff performed relatively well in history 
taking of the conditions patients presented, they 
did not perform as well in diagnosing the various 
conditions based on the patients’ account. It is of great 
concern that only a tenth offered appropriate treatment 
for the two STI conditions presented. Given the role 
that early STI treatment plays in HIV prevention, our 
findings suggest that STI self-medicating patients may 
not access appropriate treatment in such settings. This 
could contribute to fuelling the HIV pandemic since 
the role of STI management as a HIV prevention tool 
is well documented (18). One way to improve the 
quality of care self-medicating patients receive from 
retail pharmacies in slum areas is training of pharmacy 
staff in management of STI in addition to enforcement 
of legislation on the sale and procurement of restricted 
medications like antibiotics and other medications 
designated as ‘prescription only’.
In conclusion, with only about 10% offering appropriate 
Government recommended treatment for gonorrhoea 
and GUD, pharmacy staff working in retail pharmacies 
in Kibera slum put slum dwellers seeking care at an 
increased risk of STI related morbidity and transmission 
due to inappropriate or inadequate treatment. Building 
on the fact that these pharmacy staff demonstrate 
professionalism in taking history of the conditions 
presented and that approximately three fifths are able 
to correctly diagnose at least one of these two STIs, 
additional in-service training might be appropriate 
to improve management of these conditions. In 
addition, enforcement of the legislation and policy by 
appropriate bodies is clearly warranted.
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